Change in Directors/KMP
Centuple Global Ltd appoints Ajay Agarwal
Centuple Global Ltd board approved appointment of Mr. Ajay Agarwal as Additional Whole Time Director on 2026-09-24, subject to shareholder approval at an ensuing EGM.

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Bearish
4
Neutral
7
Bullish
3
Bearish
31
Neutral
7
Bullish
8
Bearish
27
Neutral
0
Bullish
5
Bearish
4
Neutral
7
Bullish
3
Bearish
4
Neutral
7
Bullish
3
Bearish
27
Neutral
0
Bullish
5
Bearish
27
Neutral
0
Bullish
5
Bearish
27
Neutral
0
Bullish
5
Pharmaceuticals & Biotechnology
Pharmaceuticals
18 Cr
Low Risk
14.8
38.1
0.0
8.8
144.40
28.42
Sales CAGR
Profit CAGR
ROE
ROCE
Centuple Global Ltd (CHECKPOINT) is currently trading at 32.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Checkpoint Trends Limited, previously known as Rubra Medicaments Ltd, was established in 1991 and is now involved in trading and consultancy services. The company has transitioned from manufacturing pharmaceutical formulations to offering a broad array of consulting services across various sectors. Checkpoint Trends Limited is actively exploring alternative business opportunities, indicating a shift in its strategic direction to diversify its offerings. The company's operations now emphasize providing high-quality consulting services at competitive prices, showcasing its flexibility in adapting to market demands.
Over the past 52 weeks, Centuple Global Ltd has traded between a low of ₹28.42 and a high of ₹144.40. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Centuple Global Ltd has a market capitalization of approximately 18.25. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Centuple Global Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 14.84 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 18.25 Cr, Centuple Global Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Centuple Global Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Centuple Global Ltd is 14.84. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Change in Directors/KMP
Centuple Global Ltd board approved appointment of Mr. Ajay Agarwal as Additional Whole Time Director on 2026-09-24, subject to shareholder approval at an ensuing EGM.
Board Meeting
Centuple Global Ltd informed BSE that a Board meeting will be held on 2026-09-24 to consider and approve the appointment of a Whole-Time Director.